奥美拉唑与兰索拉唑缓解功能性消化不良疗效的比较评价:一项系统综述

Shahnoor K. Gowani, D. Rana
{"title":"奥美拉唑与兰索拉唑缓解功能性消化不良疗效的比较评价:一项系统综述","authors":"Shahnoor K. Gowani, D. Rana","doi":"10.32892/jmri.155","DOIUrl":null,"url":null,"abstract":"Introduction: Functional dyspepsia (FD) is defined as a condition chronically presenting symptoms centered in the upper abdomen, such as epigastric pain or discomfort, in the absence of any organic, systemic, or metabolic disease that is likely to explain the symptoms. Proton pump inhibitors are main line agents to treat functional Dyspepsia. Omeprazole is conventional PPI and Lansoprazole is a new PPI both are said to be effective option to treat functional dyspepsia in individual trials. \nAim and Objective: To compare efficacy of Omeprazole versus Lansoprazole for Relief of Functional Dyspepsia. \nMethodology: All randomised control trials which follows PRISMA guidelines 2009 and in which Omeprazole and Lansoprazole were first compared with placebo for the treatment of functional dyspepsia. Clinical trial registries, MEDLINE, SCOPUS, EMBASE database were searched for MeSH terms Omeprazole, Pantoprazole, Placebo which resulted in the treatment of Functional Dyspepsia. Observational studies, Unpublished studies, RCTs not following PRISMA guidelines were excluded. Data was analyzed using RevMan version 5.3 ® and Odd’s Ratio was calculated to determine the difference in Early and late phases. Both Fixed and Random effect model was utilized to calculate the difference. To compare the difference between Omeprazole and Lansoprazole Fischer’s exact test was used. P value less than 0.05 was considered as statistically significant. The I2 will be used to measure the heterogeneity between studies and a value >30.0 will be considered to reflect heterogeneity. \nResults: A total of 10 studies were included consisting of 3934 patients. Omeprazole was effective than placebo to treat functional dyspepsia(Odd’s ratio=1.603, CI=1.264 to 2.033, p value less than 0.01) Lansoprazole was also effective when compared to placebo to treat functional dyspepsia. (Odd’s ratio=0.748, CI=0.553 to 1.011, p=0.058). When Omeprazole was compared to lansoprazole indirectly statistically significant difference was seen (P=0.0001). \nConclusion: Both Omeprazole and Lansoprazole are effective to treat functional dyspepsia when compared to placebo. Omeprazole is more effective than Lansoprazole to treat functional dyspepsia.","PeriodicalId":73819,"journal":{"name":"Journal of medical research and innovation","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Evaluation Of Efficacy of Omeprazole versus Lansoprazole for Relief of Functional Dyspepsia: A Systematic Review\",\"authors\":\"Shahnoor K. Gowani, D. Rana\",\"doi\":\"10.32892/jmri.155\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Functional dyspepsia (FD) is defined as a condition chronically presenting symptoms centered in the upper abdomen, such as epigastric pain or discomfort, in the absence of any organic, systemic, or metabolic disease that is likely to explain the symptoms. Proton pump inhibitors are main line agents to treat functional Dyspepsia. Omeprazole is conventional PPI and Lansoprazole is a new PPI both are said to be effective option to treat functional dyspepsia in individual trials. \\nAim and Objective: To compare efficacy of Omeprazole versus Lansoprazole for Relief of Functional Dyspepsia. \\nMethodology: All randomised control trials which follows PRISMA guidelines 2009 and in which Omeprazole and Lansoprazole were first compared with placebo for the treatment of functional dyspepsia. Clinical trial registries, MEDLINE, SCOPUS, EMBASE database were searched for MeSH terms Omeprazole, Pantoprazole, Placebo which resulted in the treatment of Functional Dyspepsia. Observational studies, Unpublished studies, RCTs not following PRISMA guidelines were excluded. Data was analyzed using RevMan version 5.3 ® and Odd’s Ratio was calculated to determine the difference in Early and late phases. Both Fixed and Random effect model was utilized to calculate the difference. To compare the difference between Omeprazole and Lansoprazole Fischer’s exact test was used. P value less than 0.05 was considered as statistically significant. The I2 will be used to measure the heterogeneity between studies and a value >30.0 will be considered to reflect heterogeneity. \\nResults: A total of 10 studies were included consisting of 3934 patients. Omeprazole was effective than placebo to treat functional dyspepsia(Odd’s ratio=1.603, CI=1.264 to 2.033, p value less than 0.01) Lansoprazole was also effective when compared to placebo to treat functional dyspepsia. (Odd’s ratio=0.748, CI=0.553 to 1.011, p=0.058). When Omeprazole was compared to lansoprazole indirectly statistically significant difference was seen (P=0.0001). \\nConclusion: Both Omeprazole and Lansoprazole are effective to treat functional dyspepsia when compared to placebo. Omeprazole is more effective than Lansoprazole to treat functional dyspepsia.\",\"PeriodicalId\":73819,\"journal\":{\"name\":\"Journal of medical research and innovation\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of medical research and innovation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32892/jmri.155\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical research and innovation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32892/jmri.155","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

引言:功能性消化不良(FD)是指在没有任何可能解释症状的器质性、全身性或代谢性疾病的情况下,以上腹部为中心的慢性症状,如上腹部疼痛或不适。质子泵抑制剂是治疗功能性消化不良的主要药物。奥美拉唑是常规PPI,兰索拉唑是一种新的PPI,在个体试验中都被认为是治疗功能性消化不良的有效选择。目的:比较奥美拉唑和兰索拉唑治疗功能性消化不良的疗效。方法:所有遵循2009年PRISMA指南的随机对照试验,其中奥美拉唑和兰索拉唑首次与安慰剂进行比较,用于治疗功能性消化不良。临床试验注册中心、MEDLINE、SCOPUS、EMBASE数据库中搜索MeSH术语奥美拉唑、泮托拉唑、安慰剂,这些术语可导致功能性消化不良的治疗。不包括观察性研究、未发表的研究、不遵循PRISMA指南的随机对照试验。使用RevMan 5.3®版对数据进行分析,并计算比值比以确定早期和晚期的差异。采用固定效应和随机效应模型来计算差异。为了比较奥美拉唑和兰索拉唑之间的差异,采用菲舍尔精确试验。P值小于0.05被认为具有统计学意义。I2将用于测量研究之间的异质性,值>30.00将被视为反映异质性。结果:共纳入10项研究,包括3934名患者。奥美拉唑在治疗功能性消化不良方面比安慰剂有效(Odd’s比值=1.603,CI=1.264至2.033,p值小于0.01)与安慰剂相比,兰索拉唑在治疗功能障碍性消化不良也有效。(Odd’s ratio=0.748,CI=0.553至1.011,p=0.058)。当奥美拉唑与兰索拉唑进行间接比较时,观察到统计学上的显著差异(p=0.0001)。结论:与安慰剂相比,奥美拉唑和兰索拉唑均能有效治疗功能性消化不良。奥美拉唑比兰索拉唑治疗功能性消化不良更有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparative Evaluation Of Efficacy of Omeprazole versus Lansoprazole for Relief of Functional Dyspepsia: A Systematic Review
Introduction: Functional dyspepsia (FD) is defined as a condition chronically presenting symptoms centered in the upper abdomen, such as epigastric pain or discomfort, in the absence of any organic, systemic, or metabolic disease that is likely to explain the symptoms. Proton pump inhibitors are main line agents to treat functional Dyspepsia. Omeprazole is conventional PPI and Lansoprazole is a new PPI both are said to be effective option to treat functional dyspepsia in individual trials. Aim and Objective: To compare efficacy of Omeprazole versus Lansoprazole for Relief of Functional Dyspepsia. Methodology: All randomised control trials which follows PRISMA guidelines 2009 and in which Omeprazole and Lansoprazole were first compared with placebo for the treatment of functional dyspepsia. Clinical trial registries, MEDLINE, SCOPUS, EMBASE database were searched for MeSH terms Omeprazole, Pantoprazole, Placebo which resulted in the treatment of Functional Dyspepsia. Observational studies, Unpublished studies, RCTs not following PRISMA guidelines were excluded. Data was analyzed using RevMan version 5.3 ® and Odd’s Ratio was calculated to determine the difference in Early and late phases. Both Fixed and Random effect model was utilized to calculate the difference. To compare the difference between Omeprazole and Lansoprazole Fischer’s exact test was used. P value less than 0.05 was considered as statistically significant. The I2 will be used to measure the heterogeneity between studies and a value >30.0 will be considered to reflect heterogeneity. Results: A total of 10 studies were included consisting of 3934 patients. Omeprazole was effective than placebo to treat functional dyspepsia(Odd’s ratio=1.603, CI=1.264 to 2.033, p value less than 0.01) Lansoprazole was also effective when compared to placebo to treat functional dyspepsia. (Odd’s ratio=0.748, CI=0.553 to 1.011, p=0.058). When Omeprazole was compared to lansoprazole indirectly statistically significant difference was seen (P=0.0001). Conclusion: Both Omeprazole and Lansoprazole are effective to treat functional dyspepsia when compared to placebo. Omeprazole is more effective than Lansoprazole to treat functional dyspepsia.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信